| 5/14/2026 | Sei Investments Co. | 328,924 | $730K | 0.0% | N/A | 0.249% | |
| 5/14/2026 | Walleye Capital LLC | 443,362 | $984K | 0.0% | -16.3% | 0.336% | |
| 5/14/2026 | State of Wyoming | 22,171 | $49K | 0.0% | N/A | 0.017% | |
| 4/27/2026 | Simplify Asset Management Inc. | 130,813 | $290K | 0.0% | N/A | 0.099% | |
| 4/20/2026 | Assenagon Asset Management S.A. | 227,742 | $506K | 0.0% | -63.1% | 0.173% | |
| 4/17/2026 | Total Clarity Wealth Management Inc. | 20,975 | $47K | 0.0% | -26.7% | 0.016% | |
| 4/17/2026 | Sovereign Financial Group Inc. | 30,000 | $67K | 0.0% | +200.0% | 0.023% | |
| 2/19/2026 | Invesco Ltd. | 33,308 | $54K | 0.0% | N/A | 0.047% | |
| 2/18/2026 | ADAR1 Capital Management LLC | 4,285,000 | $6.99M | 0.5% | +33,256.7% | 6.017% | |
| 2/18/2026 | Ikarian Capital LLC | 247,558 | $404K | 0.0% | -77.4% | 0.348% | |
Get the Latest News and Ratings for OVID and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 2/18/2026 | Quadrature Capital Ltd | 87,874 | $143K | 0.0% | +217.2% | 0.123% | |
| 2/18/2026 | Millennium Management LLC | 1,339,465 | $2.18M | 0.0% | +35.8% | 1.881% | |
| 2/18/2026 | Balyasny Asset Management L.P. | 325,000 | $530K | 0.0% | -48.0% | 0.456% | |
| 2/18/2026 | Boothbay Fund Management LLC | 155,741 | $254K | 0.0% | -68.0% | 0.219% | |
| 2/17/2026 | ADAR1 Capital Management LLC | 4,285,000 | $6.99M | 0.5% | +33,256.7% | 6.017% | |
| 2/17/2026 | Schonfeld Strategic Advisors LLC | 192,496 | $314K | 0.0% | -78.2% | 0.270% | |
| 2/17/2026 | Ally Bridge Group NY LLC | 1,785,000 | $2.91M | 3.0% | N/A | 2.507% | |
| 2/17/2026 | RA Capital Management L.P. | 10,714,000 | $17.46M | 0.2% | N/A | 15.046% | |
| 2/17/2026 | Adage Capital Partners GP L.L.C. | 3,492,000 | $5.69M | 0.0% | +158.7% | 4.904% | |
| 2/17/2026 | Graham Capital Management L.P. | 127,459 | $208K | 0.0% | N/A | 0.179% | |
| 2/16/2026 | Squarepoint Ops LLC | 39,034 | $64K | 0.0% | -66.0% | 0.055% | |
| 2/16/2026 | OMERS ADMINISTRATION Corp | 125,300 | $204K | 0.0% | N/A | 0.176% | |
| 2/16/2026 | Eventide Asset Management LLC | 4,285,000 | $6.99M | 0.1% | N/A | 6.017% | |
| 2/13/2026 | Marshall Wace LLP | 1,271,487 | $2.07M | 0.0% | +62.3% | 1.786% | |
| 2/13/2026 | Walleye Capital LLC | 530,020 | $864K | 0.0% | -11.2% | 0.744% | |
| 2/13/2026 | Affinity Asset Advisors LLC | 7,150,000 | $11.65M | 0.7% | +169.8% | 10.041% | |
| 2/13/2026 | AWM Investment Company Inc. | 899,200 | $1.47M | 0.1% | N/A | 1.263% | |
| 2/13/2026 | State Street Corp | 276,533 | $451K | 0.0% | +21.8% | 0.388% | |
| 2/13/2026 | Wells Fargo & Company MN | 720,848 | $1.18M | 0.0% | -1.4% | 1.012% | |
| 2/12/2026 | Jane Street Group LLC | 883,867 | $1.44M | 0.0% | +270.7% | 1.241% | |
| 2/12/2026 | Renaissance Technologies LLC | 1,484,478 | $2.42M | 0.0% | -26.4% | 2.085% | |
| 2/12/2026 | Federated Hermes Inc. | 3,571,000 | $5.31M | 0.0% | N/A | 5.015% | |
| 2/11/2026 | LPL Financial LLC | 30,000 | $49K | 0.0% | +150.0% | 0.042% | |
| 2/10/2026 | Goldman Sachs Group Inc. | 170,457 | $278K | 0.0% | +497.7% | 0.239% | |
| 2/9/2026 | Geode Capital Management LLC | 672,004 | $1.10M | 0.0% | +3.7% | 0.944% | |
| 2/2/2026 | Total Clarity Wealth Management Inc. | 28,600 | $47K | 0.0% | N/A | 0.040% | |
| 1/12/2026 | Benin Management CORP | 19,000 | $31K | 0.0% | N/A | 0.027% | |
| 1/9/2026 | Assenagon Asset Management S.A. | 618,019 | $1.01M | 0.0% | -33.2% | 0.868% | |
| 11/17/2025 | Qube Research & Technologies Ltd | 25,277 | $33K | 0.0% | -65.3% | 0.035% | |
| 11/17/2025 | Parkman Healthcare Partners LLC | 202,978 | $264K | 0.0% | N/A | 0.285% | |
Peptide Company Lands Exclusive MMA Wellness Partnership (Ad) A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide.
On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033. Read the full report on this small-cap peptide company now |
| 11/17/2025 | Millennium Management LLC | 986,293 | $1.28M | 0.0% | -6.3% | 1.385% | |
| 11/17/2025 | Integrated Wealth Concepts LLC | 52,900 | $69K | 0.0% | N/A | 0.074% | |
| 11/17/2025 | Bank of America Corp DE | 362,707 | $472K | 0.0% | +2,333.0% | 0.509% | |
| 11/17/2025 | Boothbay Fund Management LLC | 486,877 | $633K | 0.0% | N/A | 0.684% | |
| 11/14/2025 | Schonfeld Strategic Advisors LLC | 883,154 | $1.15M | 0.0% | N/A | 1.240% | |
| 11/14/2025 | Two Sigma Investments LP | 341,134 | $443K | 0.0% | N/A | 0.480% | |
| 11/14/2025 | Squarepoint Ops LLC | 114,923 | $149K | 0.0% | -48.0% | 0.162% | |
| 11/13/2025 | Kennedy Capital Management LLC | 1,106,638 | $1.44M | 0.0% | -26.3% | 1.556% | |
| 11/13/2025 | Private Advisor Group LLC | 25,600 | $33K | 0.0% | N/A | 0.036% | |
| 11/10/2025 | Persistent Asset Partners Ltd | 46,040 | $60K | 0.0% | N/A | 0.065% | |
| 11/7/2025 | GSA Capital Partners LLP | 265,993 | $346K | 0.0% | -64.2% | 0.374% | |
| 11/7/2025 | Vanguard Group Inc. | 2,820,813 | $3.67M | 0.0% | +7.0% | 3.967% | |
| 11/4/2025 | TLS Advisors LLC | 18,858 | $26K | 0.1% | -97.2% | 0.027% | |
| 10/17/2025 | Apollon Wealth Management LLC | 27,500 | $36K | 0.0% | N/A | 0.039% | |
| 10/7/2025 | Assenagon Asset Management S.A. | 924,576 | $1.20M | 0.0% | +112.2% | 1.300% | |
| 8/15/2025 | Rosalind Advisors Inc. | 500,000 | $165K | 0.1% | N/A | 0.703% | |
| 8/15/2025 | Rubric Capital Management LP | 478,533 | $158K | 0.0% | -91.0% | 0.673% | |
| 8/14/2025 | Jane Street Group LLC | 142,597 | $47K | 0.0% | N/A | 0.201% | |
| 8/14/2025 | Velan Capital Investment Management LP | 160,000 | $53K | 0.1% | +64.9% | 0.225% | |
| 8/13/2025 | Marshall Wace LLP | 164,721 | $54K | 0.0% | N/A | 0.232% | |
| 8/13/2025 | Kennedy Capital Management LLC | 1,502,329 | $496K | 0.0% | -13.3% | 2.113% | |
| 8/8/2025 | Geode Capital Management LLC | 643,335 | $212K | 0.0% | -51.7% | 0.905% | |
| 8/1/2025 | Y Intercept Hong Kong Ltd | 160,306 | $53K | 0.0% | N/A | 0.225% | |
| 7/11/2025 | Assenagon Asset Management S.A. | 435,620 | $144K | 0.0% | -22.3% | 0.613% | |
| 6/27/2025 | Goldman Sachs Group Inc. | 104,435 | $33K | 0.0% | -47.3% | 0.147% | |
| 5/21/2025 | Acadian Asset Management LLC | 2,088,046 | $650K | 0.0% | +12.8% | 2.936% | |
| 5/16/2025 | Goldman Sachs Group Inc. | 104,435 | $33K | 0.0% | -47.3% | 0.147% | |
| 5/16/2025 | Jacobs Levy Equity Management Inc. | 200,593 | $63K | 0.0% | -31.2% | 0.282% | |
| 5/16/2025 | Adage Capital Partners GP L.L.C. | 1,150,000 | $359K | 0.0% | +15.0% | 1.617% | |
| 5/14/2025 | Affinity Asset Advisors LLC | 667,516 | $208K | 0.0% | N/A | 0.939% | |
| 5/12/2025 | Nuveen LLC | 119,113 | $37K | 0.0% | N/A | 0.168% | |
| 5/8/2025 | XTX Topco Ltd | 93,154 | $29K | 0.0% | N/A | 0.131% | |
| 4/15/2025 | Assenagon Asset Management S.A. | 560,830 | $175K | 0.0% | +699.9% | 0.789% | |
| 2/17/2025 | Velan Capital Investment Management LP | 70,000 | $65K | 0.1% | N/A | 0.099% | |
| 2/17/2025 | Madison Avenue Partners LP | 3,722,627 | $3.48M | 0.4% | -9.6% | 5.242% | |
| 2/17/2025 | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC | 943,416 | $881K | 0.1% | +50.2% | 1.329% | |
| 2/17/2025 | Jacobs Levy Equity Management Inc. | 291,701 | $272K | 0.0% | N/A | 0.411% | |
| 2/17/2025 | Bridgeway Capital Management LLC | 229,115 | $214K | 0.0% | -26.0% | 0.323% | |
| 2/17/2025 | Bank of America Corp DE | 56,733 | $53K | 0.0% | +49.7% | 0.080% | |
| 2/17/2025 | BNP Paribas Financial Markets | 104,712 | $98K | 0.0% | -52.5% | 0.147% | |
| 2/14/2025 | Adage Capital Partners GP L.L.C. | 1,000,000 | $934K | 0.0% | N/A | 1.408% | |
| 2/13/2025 | Kennedy Capital Management LLC | 1,545,387 | $1.44M | 0.0% | +1.1% | 2.176% | |
| 2/13/2025 | Renaissance Technologies LLC | 107,700 | $101K | 0.0% | +142.0% | 0.152% | |
| 2/13/2025 | ADAR1 Capital Management LLC | 130,532 | $122K | 0.0% | +245.8% | 0.184% | |
| 2/12/2025 | TLS Advisors LLC | 680,967 | $636K | 1.5% | -11.7% | 0.959% | |
| 2/12/2025 | Takeda Pharmaceutical Co. Ltd. | 7,531,996 | $7.01M | 26.4% | N/A | 10.607% | |
| 2/12/2025 | JPMorgan Chase & Co. | 1,418,306 | $1.32M | 0.0% | -3.1% | 1.997% | |
| 2/10/2025 | Monimus Capital Management LP | 138,266 | $129K | 0.1% | N/A | 0.195% | |
| 1/30/2025 | Rhumbline Advisers | 84,078 | $79K | 0.0% | +22.3% | 0.118% | |
| 1/17/2025 | SG Americas Securities LLC | 37,636 | $35K | 0.0% | +83.9% | 0.053% | |
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history.
But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing |
| 1/14/2025 | Assenagon Asset Management S.A. | 70,114 | $65K | 0.0% | -18.7% | 0.099% | |
| 11/19/2024 | Barclays PLC | 84,175 | $98K | 0.0% | +311.2% | 0.119% | |
| 11/16/2024 | Geode Capital Management LLC | 1,317,330 | $1.56M | 0.0% | +1.1% | 1.855% | |
| 11/15/2024 | Barclays PLC | 84,175 | $98K | 0.0% | +311.2% | 0.119% | |
| 11/15/2024 | XTX Topco Ltd | 38,230 | $45K | 0.0% | +46.2% | 0.054% | |
| 11/15/2024 | Jane Street Group LLC | 38,399 | $45K | 0.0% | -61.1% | 0.054% | |
| 11/14/2024 | Verition Fund Management LLC | 74,875 | $88K | 0.0% | N/A | 0.105% | |
| 11/13/2024 | BNP Paribas Financial Markets | 220,401 | $260K | 0.0% | +4,128.7% | 0.311% | |
| 11/13/2024 | FMR LLC | 50,225 | $59K | 0.0% | +1,907.4% | 0.071% | |
| 11/5/2024 | GSA Capital Partners LLP | 260,509 | $307K | 0.0% | +118.0% | 0.367% | |